BioLife Solutions (BLFS) Misses Q2 EPS by 2c ; Offers Guidance
Tweet
Share
E-mailGet Alerts BLFS Hot Sheet
Price: $35.25 -0.79%
Revenue Growth %: +3.3%
Financial Fact:
Loss on disposal of property and equipment: -1.21K
Today's EPS Names:
PMCB, CULP, HURC, More
Revenue Growth %: +3.3%
Financial Fact:
Loss on disposal of property and equipment: -1.21K
Today's EPS Names:
PMCB, CULP, HURC, More
Join SI Premium – FREE
BioLife Solutions (NASDAQ: BLFS) reported Q2 EPS of ($0.23), $0.02 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at $39.5 million versus the consensus estimate of $43.64 million.
GUIDANCE:
BioLife Solutions sees FY2023 revenue of $144-158 million, versus the consensus of $184.1 million.
For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- BlackRock’s Rosenberg says inflation data key after jobs beat
- Samsara Inc (IOT) Tops Q2 EPS by 4c, Beats on Revenue; Offers Q3 Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
